A finance chief joined the Trump administration. Then his company unravelled
Frank Bisignano sold Fiserv stake worth hundreds of millions of dollars before problems emerged, avoiding massive loss
lates news
Read More
Safety strategies for a bubble market
With few haven options, the best choice for many investors may be to ride the stock market surge and see where it takes us
Battle for obesity biotech Metsera heats up as Pfizer sues to block rival bid
FTC fast-tracks antitrust approval of earlier deal in sign Washington could weigh in on takeover battle with Novo Nordisk
Canada launches C$6.4bn minerals push as race to counter China heats up
Ottawa uses national security legislation to accelerate production as G7 nations hunt for resources
Pfizer wins early US approval of bid to take over obesity biotech Metsera
Move is a sign Washington may intervene in dramatic public battle with Novo Nordisk over coveted weight loss start-up
US stocks ride AI hype and trade truce to 6-month winning streak
S&P 500 and Nasdaq post longest runs of monthly gains in years